Deerfield Management Company, L.P. (Series C) Kura Oncology, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$4.84 Billion
Q1 2024

A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 5,411,571 shares of KURA stock, worth $111 Million. This represents 2.38% of its overall portfolio holdings.

Number of Shares

5,411,571

Previous 5,312,733 1.86%

Holding current value

$111 Million

Previous $76.4 Million 51.09%

% of portfolio

2.38%

Previous 1.88%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.42 - $23.53 $1.33 Million - $2.33 Million	98,838 Added 1.86%	5,411,571 $115 Million
Q4 2023 Feb 14, 2024	BUY	$7.58 - $14.38 $7.12 Million - $13.5 Million	938,689 Added 21.46%	5,312,733 $76.4 Million
Q3 2023 Nov 14, 2023	BUY	$8.44 - $11.86 $9.59 Million - $13.5 Million	1,136,044 Added 35.08%	4,374,044 $39.9 Million
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $8.23 Million - $12 Million	855,000 Added 35.88%	3,238,000 $34.3 Million
Q4 2022 Feb 14, 2023	BUY	$11.23 - $16.9 $1.84 Million - $2.77 Million	163,872 Added 7.38%	2,383,000 $29.6 Million

Q3 2022 Nov 14, 2022	SELL	$12.01 - $19.45 $4.9 Million - $7.93 Million	-407,872 Reduced 15.53%	2,219,128 $30.3 Million
Q2 2022 Aug 15, 2022	SELL	$10.71 - $18.33 $19.2 Million - $32.8 Million	-1,789,361 Reduced 40.52%	2,627,000 $48.2 Million
Q1 2022 May 16, 2022	BUY	$11.78 - $16.98 $10.6 Million - $15.3 Million	902,605 Added 25.69%	4,416,361 $71 Million
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $14.6 Million - $23.5 Million	1,198,339 Added 51.75%	3,513,756 $49.2 Million
Q3 2021 Nov 15, 2021	BUY	$15.42 - $21.72 $8.04 Million - $11.3 Million	521,417 Added 29.06%	2,315,417 $43.4 Million
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $37.4 Million - $53.6 Million	1,794,000 New	1,794,000 $37.4 Million

Others Institutions Holding KURA

# of Institutions

173

Shares Held

80.4M

Call Options Held

914K

Put Options Held

120K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $1.38B
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account

Deerfield Management Company, L.P. (Series C) Kura Oncology, Inc. Transaction History